Fulgent Genetics, Inc. (FLGT)
Stock Price:
$41.63 USD
0.72 (1.76%)
Updated Aug 12, 2020 4:00 PM EDT - Market closed
After-hours: $43.85 +2.22 (5.33%) Aug 12, 7:37 PM
Key Info
| Market Cap |
909.07M |
| Revenue (ttm) |
43.75M |
| Net Income (ttm) |
2.53M |
| Shares Out |
21.84M |
| EPS (ttm) |
0.12 |
| PE Ratio |
346.92 |
| Forward PE |
270.27 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 12, 2020 |
| Last Price |
$41.63 |
| Previous Close |
$40.91 |
| Change ($) |
0.72 |
| Change (%) |
1.76% |
| Day's Open |
41.00 |
| Day's Range |
40.50 - 44.79 |
| Day's Volume |
593,545 |
| 52-Week Range |
6.70 - 44.79 |
More Stats
| Market Cap |
909.07M |
| Enterprise Value |
890.97M |
| Earnings Date (est) |
Nov 9, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
21.84M |
| Float |
10.64M |
| EPS (basic) |
0.13 |
| EPS (diluted) |
0.12 |
| FCF / Share |
-0.05 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
0.29% |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
931,205 |
| Short Ratio |
1.90 |
| Short % of Float |
8.04% |
| Beta |
1.94 |
| PE Ratio |
346.92 |
| Forward PE |
270.27 |
| P/FCF Ratio |
n/a |
| PS Ratio |
20.78 |
| PB Ratio |
9.19 |
| Revenue |
43.75M |
| Operating Income |
1.83M |
| Net Income |
2.53M |
| Free Cash Flow |
-1.15M |
| Net Cash |
18.10M |
| Net Cash / Share |
0.83 |
| Gross Margin |
42.10% |
| Operating Margin |
4.17% |
| Profit Margin |
5.80% |
| FCF Margin |
-2.63% |
| ROA |
1.50% |
| ROE |
3.66% |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (3)
| Buy |
2 |
| Overweight |
0 |
| Hold |
1 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$38.67*
(-7.11% downside)
Low
13.0
Current: $41.63
High
68.0
Target: 38.67
*Average 12-month price target from 3 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|
| Revenue | 32.53 | 21.35 | 18.73 | 18.28 | 9.58 | 1.28 |
| Revenue Growth | 52.35% | 13.99% | 2.48% | 90.85% | 649.3% | - |
| Gross Profit | 18.42 | 10.65 | 10.18 | 11.55 | 4.51 | 0.34 |
| Operating Income | -0.43 | -5.07 | -3.48 | 0.92 | -5.01 | -0.99 |
| Net Income | -0.41 | -5.61 | -2.51 | -5.35 | -8.31 | -4.28 |
| Shares Outstanding | 18.71 | 17.98 | 17.74 | 13.71 | 11.84 | - |
| Earnings Per Share | -0.02 | -0.31 | -0.14 | -1.00 | -0.61 | - |
| Operating Cash Flow | 5.52 | -0.68 | 1.33 | 4.41 | -0.97 | -4.40 |
| Capital Expenditures | -1.32 | -2.83 | -5.36 | -3.78 | -2.03 | -0.73 |
| Free Cash Flow | 4.20 | -3.51 | -4.03 | 0.63 | -3.00 | -5.13 |
| Cash & Equivalents | 28.27 | 31.03 | 26.48 | 20.87 | 0.49 | 0.17 |
| Total Debt | 2.68 | - | - | - | - | - |
| Net Cash / Debt | 25.59 | 31.03 | 26.48 | 20.87 | 0.49 | 0.17 |
| Assets | 88.76 | 53.90 | 57.18 | 58.04 | 5.83 | 2.12 |
| Liabilities | 5.98 | 2.75 | 3.01 | 3.56 | 0.69 | 0.44 |
| Book Value | 82.78 | 51.15 | 54.18 | 54.48 | 5.15 | 1.68 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Fulgent Genetics, Inc. |
| Country |
United States |
| Employees |
139 |
| CEO |
Ming Hsieh |
Stock Information
| Ticker Symbol |
FLGT |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Diagnostics & Research |
| Unique Identifier |
NASDAQ: FLGT |
| IPO Date |
September 29, 2016 |
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.